In T2DM, the evidence that THIO-HSA levels were inversely correlated with short (FPG, GLY-HSA), and long-term (HbA1c) metabolic compensation may mask the THIO-HSA role as a marker of CHD in this population. The gene discussed is ALB; the disease is coronary artery disorder.